Asia markets tumble as tech rout deepens
June 8, 2026
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, clearing the way for the third ...
Eli Lilly on Monday said it applied for full U.S. Food and Drug Administration approval of its Alzheimer's treatment, donanemab, ...
© 2024 LSD News title="Jegtheme">Jegtheme.